Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?

被引：0
|
作者：
Lee, Yong-ho [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Div Endocrinol & Metab,Dept Internal Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2015年 / 39卷 / 03期
关键词：
SITAGLIPTIN; RISK; DESIGN; TRIAL;
D O I：
10.4093/dmj.2015.39.3.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [41] Dipeptidyl Peptidase-4 Inhibitor Another Player for Cardiovascular Protection
    Murohara, Toyoaki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (03) : 277 - 279
  • [42] Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
    Tasanen, Kaisa
    Varpuluoma, Outi
    Nishie, Wataru
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [43] Resolution of Gastroparesis Symptoms With the Removal of a Dipeptidyl Peptidase-4 Inhibitor
    Nuvvula, Sri
    Rau, Prashanth
    Belkin, Dimitri
    Houghton, Jean Marie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1289 - S1289
  • [44] A dipeptidyl peptidase-4 inhibitor reverses diabetes in NOD mice
    Suarez-Pinzon, Wilma L.
    Rabinovitch, Alex
    DIABETES, 2007, 56 : A419 - A419
  • [45] Effect of dipeptidyl peptidase-4 inhibitors on complement activation
    Hoffmann-Petersen, Ingeborg T.
    Holt, Charlotte B.
    Jensen, Lisbeth
    Hage, Camilla
    Mellbin, Linda G.
    Thiel, Steffen
    Hansen, Troels K.
    Ostergaard, Jakob A.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (03)
  • [46] Effect of dipeptidyl peptidase-4 inhibition on complement activation
    Hoffmann-Petersen, Ingeborg
    Ostergaard, Jakob Appel
    Holt, Charlotte Berg
    Mellbin, Linda
    Thiel, Steffen
    Hansen, Troels Krarup
    MOLECULAR IMMUNOLOGY, 2015, 67 (01) : 144 - 144
  • [47] Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Outcome
    Kim, Kwang-il
    KOREAN CIRCULATION JOURNAL, 2018, 48 (05) : 430 - 432
  • [48] The Renoprotective Effect of Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, in a Mouse Model of Renal Fibrosis
    Kim, Nayoung
    Lee, In-Kyu
    Park, Sung Don
    Kim, Min-Ji
    Kim, Jung-Guk
    Choi, Yeon-Kyung
    Park, Keun-Gyu
    Kim, Mi-Jin
    DIABETES, 2019, 68
  • [49] Dipeptidyl Peptidase-4 Inhibitor Improves Steatohepatitis by Targeting Trail Receptor-Mediated Apoptosis Under Modulation of Dipeptidyl Peptidase-4 Expression
    Lee, Sejeong
    Lee, Minyoung
    Shin, Eugene
    Kim, Young-Eun
    Kang, Eun Seok
    Cha, Bong-Soo
    DIABETES, 2020, 69
  • [50] Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects
    Upreti, Vijay V.
    Boulton, David W.
    Li, Li
    Ching, Agatha
    Su, Hong
    LaCreta, Frank P.
    Patel, Chirag G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (01) : 92 - 102
12345